Are only haemophiliacs protected against ischemic heart disease?
Franchini
Massimo
M
Veneri
Dino
D
D000925:Anticoagulants / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000150:complications / Q000517:prevention & control; D006467:Hemophilia A / Q000150:complications*; D006579:Heterozygote; D006801:Humans; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics; D008875:Middle Aged; D009154:Mutation; D011516:Prothrombin / Q000235:genetics; D012307:Risk Factors; D013923:Thromboembolism / Q000150:complications / Q000517:prevention & control*; D014842:von Willebrand Diseases / Q000150:complications
D000925:Anticoagulants; D011516:Prothrombin; D042965:Methylenetetrahydrofolate Reductase (NADPH2)